Mevion Medical Systems, a Massachusetts company that makes proton therapy systems, announced a financing of up to $200 million led by two China Investors, HOPU Investments and YuanMing Capital. At the same time, Mevion and the two lead investors will form a China joint venture to produce, sell and service Mevion proton therapy systems in China. Joe Jochinowski, Mevion’s CEO, told ChinaBio® Today in an email that the China JV will be funded by HOPU and YuanMing, over and above their contributions to the financing. Mervin will contribute its expertise to the JV, which will include helping the JV manufacture the machine in China.
Help employers find you! Check out all the jobs and post your resume.
